Search/
Company exports
CSV downloadsPro company pages include CSV downloads for statements, ratios, chart data, and transcript indexes.
AI Cloud·CRWV
CoreWeave, Inc.
NASDAQ · US
AI hyperscaler and neocloud selling GPU cloud capacity and managed AI infrastructure for training and inference workloads.
AI relevance
Pure-play public AI cloud provider with large-scale NVIDIA GPU capacity and major AI lab and hyperscaler customers.
Price
$55.60
Change
-6.22 (-10.06%)
Market cap
$30.7B
52w range
$54–$142
Exchange
NASDAQ
Country
US
Jason's Chips
Subscribe or sign in with your Substack email for charts, exports, estimates, transcripts, filings, earnings, and news.
Price chart
CRWV market performance
Daily close for CoreWeave, Inc.
- Latest close
- $55.60
- Range move
- -$65.93 (-54.2%)
- Range high
- $139.9
- Range low
- $55.60
- Latest volume
- 81.8M
- Source
- FMP EOD
Downloads
CSVExports
Download statements, ratios, chart data, and transcript indexes.
Income statement
4 annual rowsRevenue, gross profit, R&D, operating income, EBITDA, net income, and EPS.
Balance sheet
3 annual rowsCash, receivables, inventory, PP&E, assets, debt, liabilities, and equity.
Cash flow
4 annual rowsOperating cash flow, capital expenditures, and free cash flow.
Key metrics
4 annual rowsEnterprise value, valuation multiples, returns, yields, and cash conversion.
Ratios
4 annual rowsMargins, liquidity ratios, valuation ratios, leverage, and per-share metrics.
Chart data
395 rowsFive years of daily close and volume data powering the company chart.
Transcript list
6 rowsAvailable earnings-call transcript dates by fiscal year and quarter.
StreetBuy
Analyst expectations
Rating consensus32 ratings
Strong buy
0
Buy
22
Hold
8
Sell
2
Strong sell
0
Annual estimates
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-12-31 | $12.88B | $12.77B - $13.20B | $-4.13 | $-4.76 - $-1.45 | $3.73B | -$811.5M | -$1.35B | $3.06B | 31 rev / 19 EPS |
| 2027-12-31 | $26.69B | $22.88B - $31.56B | $-2.03 | $-4.29 - $1.52 | $8.37B | -$600.7M | -$1.14B | $6.34B | 31 rev / 19 EPS |
| 2028-12-31 | $43.28B | $36.60B - $53.16B | $0.87 | $-1.64 - $2.65 | $17.51B | $1.68B | $899.3M | $10.28B | 27 rev / 15 EPS |
| 2029-12-31 | $61.06B | $52.73B - $70.57B | $6.30 | $5.18 - $7.57 | $28.88B | $4.01B | $2.74B | $14.50B | 13 rev / 9 EPS |
| 2030-12-31 | $86.95B | $75.09B - $100.50B | $16.20 | $13.32 - $19.48 | $46.75B | $9.46B | $7.05B | $20.65B | 13 rev / 6 EPS |
Quarterly estimates
| Period | Revenue avg | Revenue range | EPS avg | EPS range | EBITDA avg | EBIT avg | Net income avg | SG&A avg | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| 2026-12-30 | $4.69B | $4.63B - $4.84B | $-0.70 | $-1.41 - $1.59 | $1.79B | $133.8M | -$387.4M | $1.11B | 23 rev / 14 EPS |
| 2027-03-30 | $5.32B | $5.06B - $5.59B | $-0.72 | $-0.77 - $-0.67 | $1.97B | $125.8M | -$395.4M | $1.26B | 15 rev / 8 EPS |
| 2027-06-30 | $6.11B | $5.81B - $6.42B | $-0.61 | $-0.65 - $-0.57 | $2.24B | $186.7M | -$334.5M | $1.45B | 16 rev / 6 EPS |
| 2027-09-30 | $7.09B | $6.75B - $7.46B | $-0.49 | $-0.52 - $-0.46 | $2.56B | $251.1M | -$270.1M | $1.68B | 17 rev / 6 EPS |
| 2027-12-30 | $8.18B | $7.78B - $8.60B | $-0.27 | $-0.29 - $-0.26 | $2.97B | $370.8M | -$150.4M | $1.94B | 18 rev / 12 EPS |
| 2028-03-30 | $9.16B | $8.72B - $9.64B | $-0.39 | $-0.42 - $-0.37 | $3.24B | $306.6M | -$214.6M | $2.18B | 10 rev / 13 EPS |
| 2028-06-30 | $9.98B | $9.50B - $10.50B | $-0.13 | $-0.14 - $-0.12 | $3.73B | $449.1M | -$72.1M | $2.37B | 10 rev / 7 EPS |
| 2028-09-30 | $11.08B | $10.54B - $11.66B | $0.12 | $0.11 - $0.13 | $4.28B | $603.8M | $65.2M | $2.63B | 11 rev / 11 EPS |
Price target history
| Window | Targets | Average target |
|---|---|---|
| Last month | 7 | $139.14 |
| Last quarter | 23 | $139.78 |
| Last year | 60 | $129.15 |
| All time | 75 | $123.12 |
Sources: StreetInsider
Latest grade actions
| Date | Firm | Action | Previous | New |
|---|---|---|---|---|
| 2026-10-21 | Piper Sandler | Maintain | Overweight | Overweight |
| 2026-10-20 | HSBC | Maintain | Reduce | Reduce |
| 2026-10-19 | Goldman Sachs | Upgrade | Neutral | Buy |
| 2026-10-15 | Mizuho | Maintain | Neutral | Neutral |
| 2026-10-05 | Freedom Capital Markets | Maintain | Buy | Buy |
| 2026-10-02 | Cantor Fitzgerald | Maintain | Overweight | Overweight |
| 2026-10-01 | Rosenblatt | Maintain | Buy | Buy |
| 2026-09-30 | Freedom Capital Markets | Maintain | Buy | Buy |
Historical rating snapshots
| Date | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| 2026-10-01 | 8 | 24 | 8 | 2 | 1 |
| 2026-09-01 | 8 | 23 | 10 | 2 | 1 |
| 2026-08-01 | 6 | 21 | 10 | 1 | 1 |
| 2026-07-01 | 5 | 21 | 11 | 1 | 1 |
| 2026-06-01 | 4 | 20 | 11 | 1 | 1 |
| 2026-05-01 | 3 | 20 | 11 | 1 | 1 |
| 2026-04-01 | 3 | 20 | 11 | 1 | 1 |
| 2026-03-01 | 3 | 18 | 12 | 1 | 1 |
FinancialsFY 2025
Financials
Income statement annual
| Period | Revenue | Gross profit | Gross margin | R&D | Operating income | EBITDA | Net income | EPS |
|---|---|---|---|---|---|---|---|---|
| FY 2025 | $5.13B | $3.68B | 71.7% | $0 | -$46.0M | $2.47B | -$1.17B | $-2.75 |
| FY 2024 | $1.92B | $1.42B | 74.3% | $0 | $324.0M | $480.0M | -$863.0M | $-2.02 |
| FY 2023 | $229.0M | $160.0M | 69.9% | $0 | -$14.0M | -$427.0M | -$594.0M | $-1.47 |
| FY 2022 | $15.8M | $3.7M | 23.4% | $0 | -$22.9M | -$13.9M | -$31.1M | $-0.08 |
Cash flow annual
| Period | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|
| FY 2025 | $3.06B | $10.31B | -$7.25B |
| FY 2024 | $2.75B | $8.70B | -$5.95B |
| FY 2023 | $1.83B | $2.94B | -$1.11B |
| FY 2022 | $910,000 | $72.4M | -$71.5M |
Balance sheet annual
| Period | Cash + ST inv. | Receivables | Inventory | PP&E | Assets | Debt | Net debt | Liabilities | Equity |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | $3.98B | $3.17B | $0 | $38.79B | $49.30B | $29.82B | $25.88B | $45.97B | $3.33B |
| FY 2024 | $1.36B | $425.7M | $0 | $14.50B | $17.83B | $10.62B | $9.26B | $18.25B | -$413.6M |
| FY 2023 | $219.5M | $183.0M | $0 | $3.95B | $4.98B | $2.00B | $1.78B | $5.57B | -$596.6M |
Annual ratios and key metrics
| Period | Gross margin | Op margin | Net margin | Current | Quick | ROE | ROIC | EV / sales | EV / EBITDA | FCF yield | R&D / rev. | Cash cycle |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | 71.7% | -0.9% | -22.7% | 0.5x | 0.5x | -35.0% | -0.1% | 11.1x | 23.1x | -23.3% | 0.0% | -182d |
| FY 2024 | 74.3% | 16.9% | -45.1% | 0.4x | 0.4x | 208.7% | 2.1% | 9.4x | 37.5x | -68.3% | 0.0% | -562d |
| FY 2023 | 69.9% | -6.1% | -259.4% | 0.5x | 0.5x | 99.6% | -0.3% | 41.3x | -22.2x | -14.5% | 0.0% | -2118d |
| FY 2022 | 23.4% | -144.5% | -196.2% | 0.0x | 0.0x | 0.0% | 0.0% | 0.0x | 0.0x | -1.0% | 0.0% | 0d |
Annual growth
| Period | Revenue | Gross profit | R&D | Op income | Net income | EPS | FCF | Capex | Cash + ST inv. | Inventory | Assets | Debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | +167.9% | +158.6% | 0.0% | -114.2% | -35.2% | -36.1% | -21.8% | -18.5% | +192.4% | 0.0% | +176.5% | +180.8% |
| FY 2024 | +736.2% | +788.8% | 0.0% | +2414.3% | -45.3% | -37.4% | -436.1% | -195.7% | +520.0% | 0.0% | +258.3% | +431.1% |
| FY 2023 | +1346.6% | +4215.0% | 0.0% | +38.8% | -1812.7% | -1811.6% | -1453.2% | -3964.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| FY 2022 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | -- | -- |
Segments
Revenue Mix
Latest product mix
Not available.
Latest geography mixFY 2025 · $5.13B
UNITED STATES$4.80B · 93.6%
Non-US$330.0M · 6.4%
Product revenue annual
No segment history on file.
Geography revenue annual
| Period | Total | UNITED STATES | Non-US |
|---|---|---|---|
| FY 2025 | $5.13B | $4.80B | $330.0M |
Transcripts6 on file
Transcripts
Events
Events
Next earnings
2026-11-09EPS est $-1.28
Latest news
- CoreWeave set off a wave of anxiety — but Wall Street's dire prognosis is premature
Market Watch · 2026-10-22
- Stock Market Today, Oct. 22: CoreWeave Slides on Bernstein Downgrade and Financing Worries
The Motley Fool · 2026-10-22